- Merck ADC, licensed from China, hits mark in first big global trial<figure><div><img src="https://imgproxy.divecdn.com/uVCmFVeeuWUAZDwwP15hoBV13Yqshc1olOZLln_B1Fk/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNjM1MjY0NDM3XzEua…BioPharma Dive · 2mo ago↗ source
- Høeg fired in latest FDA shakeup; 20 people die after taking Amgen drug<figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…BioPharma Dive · 2mo ago↗ source
- Regeneron immunotherapy combo comes up short in melanoma trial<p>A two-drug regimen of Regeneron’s fianlimab and Libtayo didn’t significantly outperform Keytruda in a late-stage study, a finding that surprised Wall Street analysts and wiped out bi…